Pearl H Seo

Assistant Professor of Clinical

Pathology

Phone305-243-9587
Emailpseo@umail.miami.edu

587 Citations

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Pearl H Seo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Neoplasms Medicine & Life Sciences

Breast Neoplasms Medicine & Life Sciences

docetaxel Medicine & Life Sciences

gemcitabine Medicine & Life Sciences

Comorbidity Medicine & Life Sciences

Geriatric Assessment Medicine & Life Sciences

Survivors Medicine & Life Sciences

Heterografts Medicine & Life Sciences

Research Output 2000 2013

587 Citations
20 Article

5 Citations (Scopus)

Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays

Valdes, C., Seo, P. H., Tsinoremas, N. & Clarke, J., Apr 18 2013, In : Journal of Clinical Bioinformatics. 3, 1, 8.

Research output: Contribution to journal › Article

Heterografts

RNA

Genes

Consensus Sequence

Neoplasms

49 Citations (Scopus)

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer

Montero, A. J., Diaz-Montero, C. M., Deutsch, Y. E., Hurley, J., Koniaris, L. G., Rumboldt, T., Yasir, S., Jorda, M., Garret-Mayer, E., Avisar, E., Slingerland, J. M., Silva, O., Welsh, C., Schuhwerk, K., Seo, P. H., Pegram, M. D. & Glück, S., Feb 1 2012, In : Breast Cancer Research and Treatment. 132, 1, p. 215-223 9 p.

Research output: Contribution to journal › Article

docetaxel

Neoadjuvant Therapy

Doxorubicin

Cyclophosphamide

Breast Neoplasms

5 Citations (Scopus)

Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis?

Song, X., Ma, Q., Liu, X., Seo, P. H., Herderick, E., Webster, K. A., Goldschmidt-Clermont, P. & Seo, D. M., Jan 1 2012, In : Antioxidants and Redox Signaling. 16, 1, p. 85-91 7 p.

Research output: Contribution to journal › Article

Intravenous Injections

Bone Marrow Cells

Atherosclerosis

Bone

Repair

53 Citations (Scopus)

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Lobo, C., Lopes, G., Baez, O., Castrellon, A., Ferrell, A., Higgins, C., Hurley, E., Hurley, J., Reis, I., Richman, S. P., Seo, P. H., Silva, O., Slingerland, J. M., Tukia, K., Welsh, C. & Glück, S., Sep 1 2010, In : Breast Cancer Research and Treatment. 123, 2, p. 427-435 9 p.

Research output: Contribution to journal › Article

gemcitabine

Breast Neoplasms

Disease-Free Survival

Nanoparticles

Therapeutics

Response

Iorns, E., Hnatyszyn, H. J., Seo, P. H., Clarke, J., Ward, T. & Lippman, M. E., Dec 15 2010, In : Journal of the National Cancer Institute. 102, 24, p. 1880-1881 2 p.

Research output: Contribution to journal › Article